Monto A - Search Results

1

Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases.

Hui CK, Monto A, Belaye T, Lau E, Wright TL. Hui CK, et al. Among authors: monto a. Gut. 2003 Nov;52(11):1644-8. doi: 10.1136/gut.52.11.1644. Gut. 2003. PMID: 14570736 Free PMC article.

2

Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation.

Hui CK, Lau E, Monto A, Kim M, Luk JM, Poon RT, Leung N, Lo CM, Fan ST, Lau GK, Wright TL. Hui CK, et al. Among authors: monto a. Am J Transplant. 2006 Jul;6(7):1600-8. doi: 10.1111/j.1600-6143.2006.01370.x. Am J Transplant. 2006. PMID: 16827860 Free article.

3

Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection.

Hui CK, Lau E, Wu H, Monto A, Kim M, Luk JM, Lau GK, Wright TL. Hui CK, et al. Among authors: monto a. J Clin Virol. 2006 Feb;35(2):185-92. doi: 10.1016/j.jcv.2005.07.003. Epub 2005 Aug 15. J Clin Virol. 2006. PMID: 16103008

4

The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.

Seal KH, Monto A, Dove L, Shen H, Vittinghoff E, Tracy D, Miller E, Lau E, Wright TL. Seal KH, et al. Among authors: monto a. Dig Dis Sci. 2007 Dec;52(12):3423-30. doi: 10.1007/s10620-006-9277-z. Epub 2007 Apr 19. Dig Dis Sci. 2007. PMID: 17443407

5

Risks of a range of alcohol intake on hepatitis C-related fibrosis.

Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, Wright TL. Monto A, et al. Hepatology. 2004 Mar;39(3):826-34. doi: 10.1002/hep.20127. Hepatology. 2004. PMID: 14999703

6

Viral evolution of hepatitis C in injection drug users.

Dove L, Phung Y, Bzowej N, Kim M, Monto A, Wright TL. Dove L, et al. Among authors: monto a. J Viral Hepat. 2005 Nov;12(6):574-83. doi: 10.1111/j.1365-2893.2005.00640.x. J Viral Hepat. 2005. PMID: 16255758

7

Liver disease in injection drug users with hepatitis C, with and without HIV coinfection.

Monto A, Currie S, Wright TL. Monto A, et al. J Addict Dis. 2008;27(2):49-59. doi: 10.1300/J069v27n02_06. J Addict Dis. 2008. PMID: 18681191 Review.

8

The epidemiology and prevention of hepatocellular carcinoma.

Monto A, Wright TL. Monto A, et al. Semin Oncol. 2001 Oct;28(5):441-9. doi: 10.1016/s0093-7754(01)90137-x. Semin Oncol. 2001. PMID: 11685737 Review.

9

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.

Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Monto A, et al. Hepatology. 2002 Sep;36(3):729-36. doi: 10.1053/jhep.2002.35064. Hepatology. 2002. PMID: 12198667

10

Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.

Monto A, Dove LM, Bostrom A, Kakar S, Tien PC, Wright TL. Monto A, et al. Hepatology. 2005 Aug;42(2):310-6. doi: 10.1002/hep.20805. Hepatology. 2005. PMID: 16025515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

489 results

Search Page

Filters